Not many Pharma Companies are like ACR that I can tell. Eg Developing drugs for others to market - distribute under licence. So companies that may like a development arm/ section on their books may find ACR a viable option. Especially if/ when 3-4 dossiers have been approved by the FDA and the drug Development pipeline is humming along nicely, with royalties coming in. ACR has patents on its drug delivery methods through the skin, and other patents. I’m still wondering what ever happened to IP internal code ACR 065. ACR has stated that ACR065 has the potential to be bigger than Axrion. With 20 odd years of successful drug development behind it, who knows what gems are on the books waiting to be developed. Jet
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.747M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 617000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 646239 | 2 |
View Market Depth
| Last trade - 09.06am 19/06/2025 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable